Yi-Xin Zeng

18.3k total citations · 2 hit papers
183 papers, 11.3k citations indexed

About

Yi-Xin Zeng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yi-Xin Zeng has authored 183 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 79 papers in Oncology and 49 papers in Cancer Research. Recurrent topics in Yi-Xin Zeng's work include Viral-associated cancers and disorders (33 papers), Cancer-related molecular mechanisms research (26 papers) and RNA modifications and cancer (24 papers). Yi-Xin Zeng is often cited by papers focused on Viral-associated cancers and disorders (33 papers), Cancer-related molecular mechanisms research (26 papers) and RNA modifications and cancer (24 papers). Yi-Xin Zeng collaborates with scholars based in China, United States and Hong Kong. Yi-Xin Zeng's co-authors include Jian‐Yong Shao, Wei-Hua Jia, Ma-Yan Huang, Dan Xie, Qiong Shao, Li‐Xu Yan, Qiu-Liang Wu, Ling Deng, Tiebang Kang and Hsiang‐Fu Kung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Yi-Xin Zeng

182 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

2008 956 citations Li‐Xu Yan, Ma-Yan Huang et al. profile →
Global trends in incidence and mortality of nasopharyngeal carcinoma

2016 308 citations Yi-Xin Zeng, Wei-Hua Jia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi-Xin Zeng China	59	6.8k	3.8k	3.6k	1.8k	945	183	11.3k
Mu‐Sheng Zeng China	57	6.8k 1.0×	4.0k 1.0×	4.2k 1.2×	1.6k 0.9×	1.1k 1.2×	297	11.7k
Daniel E. Johnson United States	46	8.4k 1.2×	2.3k 0.6×	4.3k 1.2×	2.2k 1.2×	737 0.8×	133	13.6k
Carter Van Waes United States	58	4.5k 0.7×	2.7k 0.7×	3.8k 1.0×	2.3k 1.3×	443 0.5×	155	8.9k
Ya Cao China	58	7.2k 1.1×	4.7k 1.2×	3.9k 1.1×	2.2k 1.3×	1.3k 1.4×	311	12.6k
Kwok Wai Lo Hong Kong	65	7.4k 1.1×	4.4k 1.2×	6.5k 1.8×	1.5k 0.9×	1.4k 1.4×	265	14.6k
Walter N. Hittelman United States	62	7.4k 1.1×	2.5k 0.7×	3.8k 1.0×	984 0.6×	465 0.5×	223	12.2k
Alexandra Giatromanolaki Greece	65	7.6k 1.1×	5.9k 1.6×	4.2k 1.2×	2.0k 1.1×	1.6k 1.7×	389	15.3k
Efthimios Sivridis Greece	55	5.2k 0.8×	4.3k 1.1×	2.6k 0.7×	953 0.5×	1.3k 1.4×	245	10.2k
Tim Crook United Kingdom	54	6.5k 0.9×	2.3k 0.6×	5.2k 1.4×	1.0k 0.6×	2.4k 2.5×	120	11.1k
Giovanni Blandino Italy	61	9.2k 1.4×	4.0k 1.1×	5.2k 1.4×	813 0.5×	551 0.6×	266	12.8k

Countries citing papers authored by Yi-Xin Zeng

Since Specialization

Citations

This map shows the geographic impact of Yi-Xin Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Xin Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Xin Zeng more than expected).

Fields of papers citing papers by Yi-Xin Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Xin Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Xin Zeng. The network helps show where Yi-Xin Zeng may publish in the future.

Co-authorship network of co-authors of Yi-Xin Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Xin Zeng. A scholar is included among the top collaborators of Yi-Xin Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Xin Zeng. Yi-Xin Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Yi-Xin, et al.. (2024). DesignWatch: Analyzing Users' Operations of Mobile Apps Based on Screen Recordings. 1–7.

Deng, Cheng‐Cheng, Yuchen Zhang, Hao-Jiong Zhang, et al.. (2018). TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis. Cancer Research. 78(13). 3469–3483. 34 indexed citations

Liu, Zhiwei, Ellen T. Chang, Qing Liu, et al.. (2016). Oral Hygiene and Risk of Nasopharyngeal Carcinoma—A Population-Based Case–Control Study in China. Cancer Epidemiology Biomarkers & Prevention. 25(8). 1201–1207. 38 indexed citations

Cai, Mu-Yan, Feng-Wei Wang, Chang-Peng Li, et al.. (2016). Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Chinese Journal of Cancer. 35(1). 80–80. 14 indexed citations

Deng, Cheng‐Cheng, Miao Xu, Jing Li, et al.. (2015). Unconjugated Bilirubin Is a Novel Prognostic Biomarker for Nasopharyngeal Carcinoma and Inhibits Its Metastasis via Antioxidation Activity. Cancer Prevention Research. 9(2). 180–188. 11 indexed citations

Ye, Yan-Fang, Yan‐Qun Xiang, Fang Fang, et al.. (2015). Hepatitis B Virus Infection and Risk of Nasopharyngeal Carcinoma in Southern China. Cancer Epidemiology Biomarkers & Prevention. 24(11). 1766–1773. 26 indexed citations

Zhang, Han, Jia He, Hui-Qiang Huang, et al.. (2015). Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator. Cancer Immunology Immunotherapy. 64(12). 1587–1599. 77 indexed citations

Pan, Ke, Yong-Qiang Li, Jing-Jing Zhao, et al.. (2014). Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer. Clinical Cancer Research. 20(11). 3003–3011. 77 indexed citations

Liang, Yi, Li-Zhen Chen, Qi-Sheng Feng, et al.. (2013). Smac Mimetics in Combination with TRAIL Selectively Target Cancer Stem Cells in Nasopharyngeal Carcinoma. Molecular Cancer Therapeutics. 12(9). 1728–1737. 34 indexed citations

10.

Deng, Cheng‐Cheng, Yi Liang, Li-Zhen Chen, et al.. (2013). Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma. The International Journal of Biochemistry & Cell Biology. 45(9). 1997–2006. 44 indexed citations

11.

Zhang, Yan, Li‐Xu Yan, Qi-Nian Wu, et al.. (2011). miR-125b Is Methylated and Functions as a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer. Cancer Research. 71(10). 3552–3562. 237 indexed citations

12.

Wang, Yao, Rui-Qing Peng, Dandan Li, et al.. (2011). Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells. Chinese Journal of Cancer. 30(10). 690–700. 54 indexed citations

13.

Li, Jiang, et al.. (2011). Immunophenotyping at the Time of Diagnosis Distinguishes Two Groups of Nasopharyngeal Carcinoma Patients: Implications for Adoptive Immunotherapy. International Journal of Biological Sciences. 7(5). 607–617. 11 indexed citations

14.

Peng, Roujun, Zhong-Yu Yuan, Yi Xia, et al.. (2011). Circulating and Tumor-Infiltrating Foxp3⁺ Regulatory T Cell Subset in Chinese Patients with Extranodal NK/T Cell Lymphoma. International Journal of Biological Sciences. 7(7). 1027–1036. 8 indexed citations

15.

Hu, Zhe-Yu, Jing Wang, Gang Cheng, et al.. (2011). Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species. Chinese Journal of Cancer. 30(1). 41–53. 12 indexed citations

16.

Ren, Ze-Fang, Wensheng Liu, Hai-De Qin, et al.. (2010). Effect of family history of cancers and environmental factors on risk of nasopharyngeal carcinoma in Guangdong, China. Cancer Epidemiology. 34(4). 419–424. 42 indexed citations

17.

Jia, Wei-Hua, et al.. (2008). Molecular Diagnosis of Sentinel Lymph Node Metastases in Cervical Cancer Using Squamous Cell Carcinoma Antigen. Clinical Cancer Research. 14(17). 5571–5578. 18 indexed citations

18.

Guan, Zhong, Xiao‐Feng Zhu, Jie Xu, et al.. (2007). Aurora-A, a Negative Prognostic Marker, Increases Migration and Decreases Radiosensitivity in Cancer Cells. Cancer Research. 67(21). 10436–10444. 99 indexed citations

19.

Liu, Ji-yan, Yang Wu, Xiao-Shi Zhang, et al.. (2007). Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine. Cancer Immunology Immunotherapy. 56(10). 1597–1604. 106 indexed citations

20.

Yang, Weng-Lang, Yi-Xin Zeng, Wafik S. El‐Deiry, et al.. (1999). Transcriptional Activation of the Cyclin-Dependent Kinase Inhibitor p21 by PML/RARα. PubMed. 1(2). 125–131. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact